These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1080115)

  • 1. The origin of blood k-hydroxyindoleacetic acid following L-hydrazino-alpha-methyldopa (MK-486).
    Warsh JJ; Stancer HC
    Eur J Pharmacol; 1975 May; 32(1):128-32. PubMed ID: 1080115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The origin of blood 5-hydroxyindoleacetic acid following L-hydrazine-alpha-methyldopa (MK-486).
    Warsh JJ; Stancer HC
    Eur J Pharmacol; 1975 May; 32(1):128-32. PubMed ID: 1080116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain and peripheral metabolism of 5-hydroxytryptophan-14C following peripheral decarboxylase inhibition.
    Warsh JJ; Stancer HC
    J Pharmacol Exp Ther; 1976 Jun; 197(3):545-55. PubMed ID: 1084420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain.
    Löscher W; Pagliusi SR; Müller F
    Neuropharmacology; 1984 Sep; 23(9):1041-8. PubMed ID: 6083501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptophan and carbidopa in spontaneously hypertensive rats.
    Itskovitz HD; Werber JL; Sheridan AM; Brewer TF; Stier CT
    J Hypertens; 1989 Apr; 7(4):311-5. PubMed ID: 2786023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of midbrain raphé lesions or intracisternal 6-hydroxydopamine administration on D, L-5-hydroxytryptophan-14C metabolism after peripheral decarboxylase inhibition.
    Warsh JJ; Coscina DV; Stancer HC
    Brain Res Bull; 1976; 1(3):273-8. PubMed ID: 1086125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ipsapirone on the level of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in some regions of the rat brain.
    Gołembiowska K
    Pol J Pharmacol Pharm; 1989; 41(1):33-9. PubMed ID: 2479937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of alpha-adrenolytics on the levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in rat's brain.
    Zebrowska-Lupina I; Kleinrok Z
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):241-5. PubMed ID: 1713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of acute hypercapnia on cerebral indole amine metabolism.
    MacMillan V
    Can J Physiol Pharmacol; 1978 Apr; 56(2):223-6. PubMed ID: 305815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probenecid-induced increase of 5-hydroxytryptamine synthesis in rat brain, as measured by formation of 5-hydroxytryptophan.
    van Wijk M; Sebens JB; Korf J
    Psychopharmacology (Berl); 1979 Feb; 60(3):229-35. PubMed ID: 108699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man.
    Magnussen I; Jensen TS; Rand JH; Van Woert MH
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):184-9. PubMed ID: 6175178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of carbidopa on the concentration of rat pineal and hypothalamic indoleamines.
    Oxenkrug GF; McIntyre IM; Novak EA; Hryhorczuk LM; Frohman CE
    J Pineal Res; 1984; 1(4):349-53. PubMed ID: 6085877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of probenecid on the central nervous system of the rabbit. II. Potentiation of 5-hydroxytryptophan-induced hyperthermia and suppression of this effect by a decarboxylase inhibitor (Ro4-4602).
    Gardey-Levassort C; Olive G; Lechat P
    Pharmacology; 1974; 11(5):267-77. PubMed ID: 4546714
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotonin formation in nonblood-perfused rat kidneys.
    Stier CT; McKendall G; Itskovitz HD
    J Pharmacol Exp Ther; 1984 Jan; 228(1):53-6. PubMed ID: 6607338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pulse voltammetry in brain tissue. II. Detection of 5-hydroxyindoleacetic acid in the rat striatum.
    Cespuglio R; Faradji H; Riou F; Buda M; Gonon F; Pujol JF; Jouvet M
    Brain Res; 1981 Nov; 223(2):299-311. PubMed ID: 6169403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of 5-hydroxyindole derivates after administration of L-5-hydroxytryptophan ethyl ester.
    Korf J; Sebens JB; Venema K; van Praag HM
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):171-82. PubMed ID: 968174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of serotonin-active drugs on prolactin secretion in male rats.
    Jagiełło-Wójtowicz E; Załuska W; Szponar J; Surmaczyńska B; Wójcicki M; Kleinrok Z
    Pol J Pharmacol Pharm; 1988; 40(1):73-80. PubMed ID: 2467272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
    Maj J; Pawlowski L; Sarnek J
    Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of carbidopa on the cerebral accumulation of exogenous L-5-hydroxytryptophan in mice.
    Magnussen I
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):199-202. PubMed ID: 6334429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
    van Praag HM; Korf J
    J Nerv Ment Dis; 1974 May; 158(5):331-7. PubMed ID: 4596091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.